av/cyclo-therapeutics--big.svg

NASDAQ:CYTHW

Cyclo Therapeutics

  • Stock

USD

Last Close

0.72

26/03 20:00

Market Cap

39.49M

Beta: -

Volume Today

186.81K

Avg: 2.95K

PE Ratio

−1.53

PFCF: −2.83

OverviewFinancialsAPI

    Description

    Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition...Show More

    Earnings

    Earnings per Share (Estimate*)

    -0.5-0.4-0.3-0.2-0.12022-12-312022-12-302023-03-312023-03-302023-06-302023-06-292023-09-302023-09-29

    Revenue (Estimate*)

    200K400K600K800K1M1.20M1.40M2022-12-312022-12-302023-03-312023-03-302023-06-302023-06-292023-09-302023-09-29

    *Estimate based on analyst consensus